GE Healthcare Technologies, Inc.

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US36266G1076
USD
61.59
0.44 (0.72%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
DexCom, Inc.
IDEXX Laboratories, Inc.
Medtronic Plc
Intuitive Surgical, Inc.
Edwards Lifesciences Corp.
Agilent Technologies, Inc.
Stryker Corp.
Danaher Corp.
GE Healthcare Technologies, Inc.
Abbott Laboratories
Becton, Dickinson & Co.

Why is GE Healthcare Technologies, Inc. ?

1
High Management Efficiency with a high ROCE of 18.55%
2
Strong ability to service debt as the company has a low Debt to EBITDA ratio of 2.92 times
3
Flat results in Mar 26
  • ROCE(HY) Lowest at 19.24%
  • INTEREST COVERAGE RATIO(Q) Lowest at 549.25
  • RAW MATERIAL COST(Y) Grown by 8.97% (YoY)
4
With ROCE of 18.08%, it has a attractive valuation with a 2.32 Enterprise value to Capital Employed
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of -14.33%, its profits have fallen by -4%
5
High Institutional Holdings at 98.79%
  • These investors have better capability and resources to analyse fundamentals of companies than most retail investors.
  • Their stake has increased by 3.57% over the previous quarter.
6
Consistent Underperformance against the benchmark over the last 3 years
  • Along with generating -14.33% returns in the last 1 year, the stock has also underperformed S&P 500 in each of the last 3 annual periods
stock-recommendationReal-Time Research Report

Verdict Report

How much should you hold?

  1. Overall Portfolio exposure to GE Healthcare Technologies, Inc. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is GE Healthcare Technologies, Inc. for you?

Medium Risk, Low Return

Absolute
Risk Adjusted
Volatility
GE Healthcare Technologies, Inc.
-14.33%
-0.57
32.74%
S&P 500
25.41%
1.92
13.25%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
3.99%
EBIT Growth (5y)
2.66%
EBIT to Interest (avg)
7.73
Debt to EBITDA (avg)
2.11
Net Debt to Equity (avg)
0.70
Sales to Capital Employed (avg)
1.08
Tax Ratio
18.50%
Dividend Payout Ratio
3.08%
Pledged Shares
0
Institutional Holding
98.79%
ROCE (avg)
18.55%
ROE (avg)
26.44%
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
15
Industry P/E
Price to Book Value
3.04
EV to EBIT
12.85
EV to EBITDA
10.71
EV to Capital Employed
2.32
EV to Sales
1.80
PEG Ratio
NA
Dividend Yield
0.10%
ROCE (Latest)
18.08%
ROE (Latest)
20.79%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bearish
Bearish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bearish
Mildly Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
Mildly Bullish
No Trend
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
INVENTORY TURNOVER RATIO(HY)

Highest at 5.69 times

-11What is not working for the Company
ROCE(HY)

Lowest at 19.24%

INTEREST COVERAGE RATIO(Q)

Lowest at 549.25

RAW MATERIAL COST(Y)

Grown by 8.97% (YoY

INTEREST(Q)

Highest at USD 134 MM

OPERATING PROFIT(Q)

Lowest at USD 736 MM

OPERATING PROFIT MARGIN(Q)

Lowest at 14.34 %

PRE-TAX PROFIT(Q)

Lowest at USD 567 MM

NET PROFIT(Q)

Lowest at USD 439.46 MM

EPS(Q)

Lowest at USD 0.85

Here's what is working for GE Healthcare Technologies, Inc.

Inventory Turnover Ratio
Highest at 5.69 times
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Depreciation
Highest at USD 153 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (USD MM)

Here's what is not working for GE Healthcare Technologies, Inc.

Interest Coverage Ratio
Lowest at 549.25
in the last five periods
MOJO Watch
The company's ability to manage interest payments is deteriorating

Operating Profit to Interest

Interest
Highest at USD 134 MM
in the last five periods and Increased by 8.94% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (USD MM)

Operating Profit
Lowest at USD 736 MM
in the last five periods
MOJO Watch
Near term Operating Profit trend is negative

Operating Profit (USD MM)

Operating Profit Margin
Lowest at 14.34 %
in the last five periods
MOJO Watch
Company's profit margin has deteriorated

Operating Profit to Sales

Pre-Tax Profit
Lowest at USD 567 MM
in the last five periods
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
Lowest at USD 439.46 MM
in the last five periods
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

EPS
Lowest at USD 0.85
in the last five periods
MOJO Watch
Declining profitability; company has created lower earnings for shareholders

EPS (USD)

Raw Material Cost
Grown by 8.97% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Non Operating Income
Highest at USD 0.23 MM
in the last five periods
MOJO Watch
Increased income from non business activities may not be sustainable

Non Operating income